undamentalytics Newsletter

Causey Christopher: insider trades

Director at United Therapeutics Corp. No open-market purchases and 21 sales not made under a pre-set plan, reported from January 8, 2010 to September 25, 2025.

What happened after Causey Christopher’s sales?

After their sales, the shares moved −2.5% against the index over 12 months on average (a negative figure means selling was the right call); 62% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Causey Christopher: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 21 +1.1% +0.1% 48% 7 0.65 0.54 No reliable evidence
Sales, 12 months after the report 21 −2.5% −2.0% 62% 7 −0.03 0.97 No reliable evidence
Sales, 12 months after the trade 21 −3.1% −1.8% 67% 7 −0.15 0.89 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
United Therapeutics Corp UTHR —021January 8, 2010September 25, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
September 25, 2025September 24, 2025 UTHR Sale $440,000 +12.6%−5.4%−9.6%
November 4, 2024November 1, 2024 UTHR Sale $192,081 −13.7%−0.5%−0.5%
August 22, 2024August 21, 2024 UTHR Sale $422,290 −0.4%−28.7%−29.2%
June 20, 2024June 18, 2024 UTHR Sale $912,540 +7.0%−22.4%−17.6%
June 14, 2024June 13, 2024 UTHR Sale $563,060 +12.9%−12.5%−11.8%
May 16, 2024May 15, 2024 UTHR Sale $545,800 +21.1%+1.4%−1.7%
May 6, 2024May 3, 2024 UTHR Sale $582,198 +20.4%+2.7%+5.8%
December 18, 2023December 15, 2023 UTHR Sale $102,000 −11.7%+25.3%+24.1%
December 13, 2023December 12, 2023 UTHR Sale $749,040 −17.4%+16.4%+11.7%
August 25, 2022August 23, 2022 UTHR Sale $787,360 +24.8%−6.0%−5.9%
May 26, 2022May 26, 2022 UTHR Sale $1,117,733 −5.2%−13.4%−14.1%
September 10, 2018September 10, 2018 UTHR Sale $96,390 −1.7%−40.8%−38.0%
November 28, 2012November 26, 2012 UTHR Sale $79,995 +6.6%+44.1%+41.4%
July 1, 2010July 1, 2010 UTHR Sale $95,000 +3.1%−19.5%−17.1%
June 3, 2010June 3, 2010 UTHR Sale $103,740 −8.1%−2.0%−1.4%
May 7, 2010May 6, 2010 UTHR Sale $108,260 +0.1%+6.3%+4.5%
April 2, 2010April 1, 2010 UTHR Sale $110,280 +0.2%+5.3%+6.7%
March 5, 2010March 4, 2010 UTHR Sale $116,480 −5.8%−1.4%−0.7%
March 1, 2010February 26, 2010 UTHR Sale $17,130 −10.5%−4.6%−3.4%
February 12, 2010February 11, 2010 UTHR Sale $118,420 −12.8%−5.8%−13.1%
January 8, 2010January 7, 2010 UTHR Sale $106,440 +1.0%+9.7%+5.7%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Causey Christopher traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.